Your Account
close button

Use our patient tools for secure, convenient, 24/7 access. Learn more

This facility is a member of


Connect with us:

News

Manchester Memorial Hospital Named ‘Top Performer’ by the Joint Commission

 

Manchester, KY – Manchester Memorial Hospital (MMH) has been recognized as a 2014 Top Performer on Key Quality Measures® by the Joint Commission, the leading accreditor of health care organizations in the United States.

 

MMH was recognized as part of the Joint Commission’s 2015 annual report “America’s Hospitals: Improving Quality and Safety,” for attaining and sustaining excellence in accountability measure performance for heart failure, pneumonia, VTE and immunization. MMH is one of only 1,043 hospitals out of more than 3,300 eligible hospitals in the United States to achieve the 2014 Top Performer distinction.

 

“We understand what matters most to patients at MMH is the quality and safety of the care they receive. That is why we have made it a top priority to improve positive patient outcomes through evidence-based care processes,” said Erika Skula, CEO of MMH. “Manchester Memorial Hospital is proud to be named a Top Performer as it recognizes the knowledge, teamwork and dedication of our entire hospital staff.”

  

To be a 2014 Top Performer, hospitals had to meet three performance criteria based on 2014 accountability measure data, including:

  • Achieve cumulative performance of 95 percent or above across all reported accountability measures;
  • Achieve performance of 95 percent or above on each and every reported accountability measure with at least 30 denominator cases; and
  • Have at least one core measure set that had a composite rate of 95 percent or above, and within that measure set, achieve a performance rate of 95 percent or above on all applicable individual accountability measures.


“Delivering the right treatment in the right way at the right time is a cornerstone of high-quality health care. I commend the efforts of Manchester Memorial Hospital for their excellent performance on the use of evidence-based interventions,” said Mark R. Chassin, MD, FACP, MPP, MPH, president and CEO, the Joint Commission.

*published in the Manchester Enterprise